4//SEC Filing
Hutson Nancy J 4
Accession 0001127602-23-018775
CIK 0000882796other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:33 PM ET
Size
8.7 KB
Accession
0001127602-23-018775
Insider Transaction Report
Form 4
Hutson Nancy J
Director
Transactions
- Award
Automatic Stock Option Grant
2023-06-13+39,072→ 39,072 totalExercise: $8.18From: 2024-06-13Exp: 2033-06-13→ Common Stock (39,072 underlying) - Award
Common Stock
2023-06-13+16,745→ 94,684 total - Sale
Common Stock
2023-06-14$8.04/sh−12,866$103,443→ 81,818 total
Footnotes (3)
- [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- [F2]The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $7.89 to $8.12. The reporting person will provide to the issuer, or any security holder of the issuer, or the SEC staff upon request, full information regarding the number of shares purchased at each price within the range set forth in the footnote.
- [F3]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001379222
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:33 PM ET
- Size
- 8.7 KB